Related Experiment Video
Updated: Jun 9, 2026
08:58
Murine Kidney Transplant Technique
Published on: October 20, 2015
[Kidney transplantation: how shall we deal with marginal cases? Future prospects from basic research]
Naotsugu Ichimaru1, Koji Yazawa, Shiro Takahara
1Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine.
Hinyokika Kiyo. Acta Urologica Japonica
|September 3, 2010
Summary
Researchers explored novel treatments for renal ischemia-reperfusion injury. MF-1 and carbamylated erythropoietin (CEPO) protected kidney cells from damage and promoted recovery in animal models.
Area of Science:
- Nephrology
- Regenerative Medicine
- Transplantation Immunology
Context:
- Renal ischemia-reperfusion (I/R) injury is a significant challenge in kidney transplantation, impacting long-term graft survival.
- Protecting kidneys from I/R injury is crucial for improving transplant outcomes.
Purpose:
- To investigate the protective effects of MF-1 and carbamylated erythropoietin (CEPO) against renal I/R injury.
- To evaluate novel therapeutic strategies for mitigating kidney damage post-transplantation.
Summary:
- MF-1, a growth factor chimera, prevented apoptosis and necrosis in cultured kidney cells and ameliorated renal dysfunction in a rat I/R model.
- CEPO demonstrated organ protection without increasing hemoglobin, promoting angiogenesis and reducing tubular apoptosis in a rat I/R model.
Impact:
- Identified MF-1 as a potential agent to protect against hypoxia-induced kidney cell death.
- Established CEPO as a promising therapeutic approach for renal protection via angiogenesis promotion in I/R injury.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...